Patients who are homozygous for defective gene for enzyme

in 1990, the first human gene therapy experiment on a patient with adenosine deaminase deficiency was done. Patients who are homozygous for a defective gene for this enzyme have defective immune systems and risk death from diseases as simple as a common cold. Which cells were involved, and how were they engineered?

"Is this question part of your assignment? We can help"